Endolysins against Streptococci as an antibiotic alternative.

Front Microbiol · 2022 · PMC9378833 · PMID 35983327

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Therefore, the use of purified endolysins to treat pneumococcal infections is warranted due to an increasing trend of antimicrobial resistance ( Jado et al., 2003 ; Hauser et al., 2012 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.